132 related articles for article (PubMed ID: 30730018)
1. Physiologic serum 1,25 dihydroxyvitamin D is inversely associated with prostatic Ki67 staining in a diverse sample of radical prostatectomy patients.
Rosenberg A; Nettey OS; Gogana P; Sheikh U; Macias V; Kajdacsy-Balla A; Sharifi R; Kittles RA; Murphy AB
Cancer Causes Control; 2019 Feb; 30(2):207-214. PubMed ID: 30730018
[TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and ki67 labeling in prostate cancer patients.
Wagner D; Trudel D; Van der Kwast T; Nonn L; Giangreco AA; Li D; Dias A; Cardoza M; Laszlo S; Hersey K; Klotz L; Finelli A; Fleshner N; Vieth R
J Clin Endocrinol Metab; 2013 Apr; 98(4):1498-507. PubMed ID: 23463655
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D and genetic ancestry are associated with apoptosis rates in benign and malignant prostatic epithelium.
Stinson J; McCall C; Dobbs RW; Mistry N; Rosenberg A; Nettey OS; Sharma P; Dixon M; Sweis J; Macias V; Sharifi R; Kittles RA; Kajdacsy-Balla A; Murphy AB
Prostate; 2023 Mar; 83(4):352-363. PubMed ID: 36479698
[TBL] [Abstract][Full Text] [Related]
4. Prostatic compensation of the vitamin D axis in African American men.
Richards Z; Batai K; Farhat R; Shah E; Makowski A; Gann PH; Kittles R; Nonn L
JCI Insight; 2017 Jan; 2(2):e91054. PubMed ID: 28138564
[No Abstract] [Full Text] [Related]
5. Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy.
Nyame YA; Murphy AB; Bowen DK; Jordan G; Batai K; Dixon M; Hollowell CM; Kielb S; Meeks JJ; Gann PH; Macias V; Kajdacsy-Balla A; Catalona WJ; Kittles R
J Clin Oncol; 2016 Apr; 34(12):1345-9. PubMed ID: 26903577
[TBL] [Abstract][Full Text] [Related]
6. Baseline serum 25-hydroxyvitamin d levels in men undergoing radical prostatectomy: is there an association with adverse pathologic features?
Berg WT; Shapiro EY; Rothberg MB; Bergman A; Scarberry K; Wambi C; Patel T; Badani KK
Clin Genitourin Cancer; 2014 Oct; 12(5):330-4. PubMed ID: 24680790
[TBL] [Abstract][Full Text] [Related]
7. Commentary on "randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and Ki67 labeling in prostate cancer patients." Wagner D, Trudel D, Van der Kwast T, Nonn L, Giangreco AA, Li D, Dias A, Cardoza M, Laszlo S, Hersey K, Klotz L, Finelli A, Fleshner N, Vieth R, Department of Nutritional Sciences, University of Toronto, Ontario, Canada.: J Clin Endocrinol Metab 2013;98(4):1498-507 [Epub 2013 Mar 5].
Olumi AF
Urol Oncol; 2014 Feb; 32(2):210. PubMed ID: 24445291
[TBL] [Abstract][Full Text] [Related]
8. Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism.
Azrad M; Zhang K; Vollmer RT; Madden J; Polascik TJ; Snyder DC; Ruffin MT; Moul JW; Brenner D; Hardy RW; Demark-Wahnefried W
PLoS One; 2012; 7(12):e53104. PubMed ID: 23285256
[TBL] [Abstract][Full Text] [Related]
9. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
Zellweger T; Günther S; Zlobec I; Savic S; Sauter G; Moch H; Mattarelli G; Eichenberger T; Curschellas E; Rüfenacht H; Bachmann A; Gasser TC; Mihatsch MJ; Bubendorf L
Int J Cancer; 2009 May; 124(9):2116-23. PubMed ID: 19117060
[TBL] [Abstract][Full Text] [Related]
10. Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy?
Murphy AB; Nyame YA; Batai K; Kalu R; Khan A; Gogana P; Dixon M; Macias V; Kajdacsy-Balla A; Hollowell CM; Catalona WJ; Kittles R
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):55-60. PubMed ID: 27725729
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies.
Tretiakova MS; Wei W; Boyer HD; Newcomb LF; Hawley S; Auman H; Vakar-Lopez F; McKenney JK; Fazli L; Simko J; Troyer DA; Hurtado-Coll A; Thompson IM; Carroll PR; Ellis WJ; Gleave ME; Nelson PS; Lin DW; True LD; Feng Z; Brooks JD
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):264-70. PubMed ID: 27136741
[TBL] [Abstract][Full Text] [Related]
12. Associations between serum vitamin D biomarkers and tumor expression of Ki67, p53, and COX-2 in colorectal cancer cases from the Southern Community Cohort Study.
Lawler T; Su T; Cai Q; Steinwandel MD; Zheng W; Blot WJ; Warren Andersen S
J Steroid Biochem Mol Biol; 2023 Jan; 225():106201. PubMed ID: 36210028
[TBL] [Abstract][Full Text] [Related]
13. Is Ki67 prognostic for aggressive prostate cancer? A multicenter real-world study.
Fantony JJ; Howard LE; Csizmadi I; Armstrong AJ; Lark AL; Galet C; Aronson WJ; Freedland SJ
Biomark Med; 2018 Jul; 12(7):727-736. PubMed ID: 29902938
[TBL] [Abstract][Full Text] [Related]
14. Effect of pathologic revision and Ki67 and ERG immunohistochemistry on predicting radical prostatectomy outcome in men initially on active surveillance.
Bokhorst LP; Roobol MJ; Bangma CH; van Leenders GJ
Prostate; 2017 Jul; 77(10):1137-1143. PubMed ID: 28543353
[TBL] [Abstract][Full Text] [Related]
15. [p53 and Ki67 expression in specimens of radical prostatectomy. Relationship with clinico-pathologic data and survival].
Zudaire Bergera JJ; Sánchez Zalabardo D; Arocena García-Tapia J; Sanz Pérez G; Díez Caballero F; López Ferrandis J; Rosell Costa D; Robles García JE; de Alava E; Berián Polo JM
Actas Urol Esp; 2000 Apr; 24(4):307-13. PubMed ID: 14964088
[TBL] [Abstract][Full Text] [Related]
16. Associations between frailty and serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations in older Australian men: the Concord Health and Ageing in Men Project.
Hirani V; Naganathan V; Cumming RG; Blyth F; Le Couteur DG; Handelsman DJ; Waite LM; Seibel MJ
J Gerontol A Biol Sci Med Sci; 2013 Sep; 68(9):1112-21. PubMed ID: 23657973
[TBL] [Abstract][Full Text] [Related]
17. Ki-67 expression predicts biochemical recurrence after radical prostatectomy in the setting of positive surgical margins.
Shahait M; Nassif S; Tamim H; Mukherji D; Hijazi M; El Sabban M; Khauli R; Bulbul M; Abou Kheir W; El Hajj A
BMC Urol; 2018 Mar; 18(1):13. PubMed ID: 29506507
[TBL] [Abstract][Full Text] [Related]
18. [The usefulness of Ki67 expression in the biopsy specimens, to predict the biochemical progresion of the prostate cancer after radical prostatectomy].
Ojea Calvo A; Mosteiro Cerviño MJ; Domínguez Freire F; Alonso Rodrigo A; Rodríguez Iglesias B; Benavente Delgado J; Barros Rodríguez JM; González Piñeiro A
Actas Urol Esp; 2004 Oct; 28(9):650-60. PubMed ID: 16050199
[TBL] [Abstract][Full Text] [Related]
19. Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men.
Shimizu Y; Segawa T; Inoue T; Shiraishi T; Yoshida T; Toda Y; Yamada T; Kinukawa N; Terada N; Kobayashi T; Kinoshita H; Kamoto T; Nakamura E; Ogawa O
BJU Int; 2007 Sep; 100(3):685-90. PubMed ID: 17542985
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort.
Richardsen E; Andersen S; Al-Saad S; Rakaee M; Nordby Y; Pedersen MI; Ness N; Grindstad T; Movik I; Dønnem T; Bremnes R; Busund LT
PLoS One; 2017; 12(11):e0186852. PubMed ID: 29141018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
